News

Maximizing Value: Shay Capital's Proposal to Beyond Inc.

Maximizing Value: Shay Capital's Proposal to Beyond Inc.

Shay Capital's Strategic Recommendations for Beyond Inc.

In a recent communication to the board members of Beyond Inc., significant shareholders expressed their appreciation for the company's remarkable turnaround under the leadership of CEO Marcus Lemonis. Beyond Inc. ($BYON) has made impressive strides in revitalizing its core operations, particularly regarding iconic brands such as Bed Bath & Beyond and Overstock. These efforts have not only restored investor confidence but have also set the stage for sustainable growth in the future.

The Importance of Monetizing Blockchain Assets

Despite the progress, there is increasing concern regarding the Medici Ventures portfolio's lack of monetization. Specifically, the direct stakes in tZero and GrainChain have not yet been maximized, leaving shareholders questioning the effectiveness of current strategies. With over $400 million invested by Beyond shareholders into these ventures over the past decade, the need to unlock the true potential of these blockchain assets becomes paramount.

Encouraging Management Actions

In the wake of discussions with investors, the management has shown a newfound urgency. Their recent letter to the tZero board indicates the initiation of a monetization strategy, which shareholders view as a positive step forward. Immediate and decisive action is essential to capitalize on these opportunities, and the board has the authority to act without further delay.

Proposed Steps for Immediate Implementation

Shay Capital has laid out specific proposals for Beyond Inc. aimed at ensuring that shareholders see a return on their investments promptly. The focus is on two primary initiatives that could unlock significant shareholder value:

1. Establishing a GrainChain Special Purpose Vehicle (SPV)

By transferring Beyond's direct ownership stake in GrainChain into an SPV, the company can issue shares of this SPV as a dividend to all Beyond shareholders. This new stock could be listed on the NYSE under the ticker "BYONS". This approach would enhance transparency regarding GrainChain's value and allow shareholders to benefit directly from its success.

2. Introducing a Contingent Value Right (CVR)

The issuance of a CVR to all Beyond shareholders, tied to the monetization of the Medici Ventures portfolio (excluding tZero and GrainChain), has also been proposed. Trading on the NYSE as "BYONR", this CVR would provide immediate value to shareholders and create a clear mechanism for realizing returns on their long-term investments.

Calling for Swift Action from the Board

Shay Capital insists that the board should set record dates for these distributions soon, to reinforce a commitment to prompt execution of these recommendations. This expectation reflects a collective desire for the company's management to engage actively with shareholder interests, signaling a proactive rather than reactive approach.

A Potential tZero IPO or SPAC Merger

The successful execution of a tZero IPO or SPAC merger could serve as a significant capital source to support Beyond's growth strategy. This could further facilitate the acquisition of strategic businesses and intellectual properties without requiring dilutive financing. As the blockchain environment evolves, tZero stands out as a leader among blockchain companies, and the success of its public transaction is pivotal for maximizing shareholder value.

Looking Ahead: The Road to Accountability

Beyond Inc. has demonstrated extraordinary progress, and the vision set forth is commendable. However, the delays in monetizing the Medici portfolio cannot continue. As shareholders, it is crucial to hold the board and management of Pelion Ventures accountable for delivering results. A response outlining the plans to execute these proposed measures is expected within 10 business days, and shareholders are eager for constructive dialogue to prioritize their interests.

Frequently Asked Questions

What is Shay Capital's main proposal to Beyond Inc.?

Shay Capital proposes creating a GrainChain SPV and issuing a CVR to enhance shareholder value from the Medici Ventures portfolio.

Why is there concern about the Medici Ventures portfolio?

Shareholders are worried that substantial investments have not been monetized, impacting returns and growth prospects.

What steps is Beyond Inc. taking in response to these concerns?

The management is currently exploring monetization strategies, as indicated by their communications with the tZero board.

How can the proposed SPV benefit shareholders?

The SPV would allow shareholders to directly own shares linked to GrainChain's success, enhancing transparency and potential returns.

What expectations does Shay Capital have regarding board actions?

Shay Capital expects prompt execution of their proposals and a detailed response from the board regarding future actions within 10 business days.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Ensign Lawsuit Brews: Investor Stakes High by Dec. 7

Updated Category News Views 0

Ensign's Alleged Missteps Uncovered Man, grabbing headlines in the finance world often feels like catching a whirlwind, and yet, here we are with Ensign Group's latest debacle. This isn't some run-of-the-mill story we're sifting through. It's a class action lawsuit with teeth, aiming to rope in investors who played ball during a hefty stretch running from February 10,...

Continue Reading
Wuhan Colposcopy Course Advances Non-Invasive Treatments

Updated Category News Views 3

Wuhan's Leap in Colposcopy Training Innovation Talk about shaking things up in the medical world—this 2026 CSCCP-ASCCP Colposcopy Training Course in Wuhan isn't just another run-of-the-mill gathering. It's a heavyweight clash of brainpower between the Chinese and American medical pros in the relentless battle against cervical lesions. But here's where it gets spicy: for...

Continue Reading
SOCaaS Market Grows to $16.68B by 2031, What It Means

Updated Category News Views 9

SOC as a Service: More Than Just Jargon The term 'SOC as a Service' (SOCaaS) might sound like some alphabet soup, but it’s a serious contender in today’s digital security world. With projected growth from $9.04 billion in 2026 to a whopping $16.68 billion by 2031, the SOCaaS market isn’t just having a moment, it’s setting up a stage for the long haul. It’s like...

Continue Reading
Middle East's Premier Jewellery Event: A Game-Changer

Updated Category News Views 6

An Event Gemmed with Strategic Importance The Middle East is about to see its streets glitter even more than usual. Next week, the Jewellery, Gem & Technology in Dubai (JGTD) event rolls into town, packed with brands that’ll drop in like swanky diamonds. We’re talking 300 heavy-duty exhibitors from all corners of the globe, ready to strut their stuff at the DEC Expo...

Continue Reading
Dimethylaminopropylamine Market Eyes $732M by 2035

Updated Category News Views 4

Surfactants and Epoxy Fuel Dimethylaminopropylamine Demand Hot off the presses, folks! Dimethylaminopropylamine, or DMAPA if you're into acronyms, is gearing up for a steady climb to a $731.9 million market value by the year 2035. That's quite the leap from the $452.6 million we saw back in 2025. According to Credence Research's latest estimates, this amine is hitching...

Continue Reading
PZZA Faces Class Action: Strategic Shake-up or Misstep?

Updated Category News Views 3

Papa John's: Doughy Deceit or Strategic Misfire? Once in a while, a corporation trips over its own ambitious production line, and Papa John’s (NASDAQ:PZZA) is the latest contestant to make headlines for all the wrong reasons. Investors in this pizza powerhouse are being called to the courtroom as a class action lawsuit unfolds, marking a turbulent stage in the...

Continue Reading
Hexagon Composites to Release Q3 2026 Results Soon

Updated Category News Views 3

Anticipating Hexagon's Third Quarter 2026 Results Hexagon Composites ASA, based out of Oslo, Norway, is setting the stage to release its third quarter 2026 financial results. Mark your calendars for November 6, 2026, at the early bird hour of 07:00 am CET. For those of us keen on dissecting the numbers, that's when the real action begins. Executive Insights Await A...

Continue Reading
Astra Security Tackles PHP2Shell Vulnerabilities Head-On

Updated Category News Views 26

Unlocking the PHP Puzzle Hot off the press, Astra Security's stepping up to the plate with some freebie tools designed to sniff out and stamp out those pesky PHP2Shell vulnerabilities—CVE-2026-109618 and CVE-2026-109619. If you're not familiar, these suckers rate a whopping 9.2 on the CVSS v4.0 scale, and that means they got the potential to let remote code execution...

Continue Reading
OwnATC Empowers Trainers to Expand Access to Care

Updated Category News Views 5

The Untapped Potential of Athletic Trainers In a hustle to get people's bodies moving and grooving right, we often overlook a crucial player: the Certified Athletic Trainer (CAT). These folks have been shelved in schools or sports arenas for far too long, especially when their expertise could be lighting up communities across the map. Enter OwnATC, shaking things up. A...

Continue Reading
NorthStar Anesthesia Focuses on ASC Partnerships

Updated Category News Views 2

NorthStar's Growing Partnerships Amid Operational Woes Anesthesia isn’t always the first thing you’d think of in big market-moving terms, but when it comes to keeping ambulatory surgery centers (ASCs) afloat, it might just be the critical stitch. ASCs are getting pinched from all sides—rising costs, staffing nightmares, and those unexpected surgical disruptions that...

Continue Reading

Top 5 Most Recently Viewed Articles

17 Education & Technology Group Reports Second Quarter Results

Updated Category News Views 136

17 Education & Technology Group Inc. Reports Q2 Results 17 Education & Technology Group Inc. (NASDAQ: YQ), a prominent education technology firm, has recently shared its impressive financial outcomes for the second quarter. This highlights their continuous growth and innovation strategy in the education sector. Second Quarter Highlights Financial Performance In its most...

Continue Reading
Akeso's 2024 Results Conference Call: Insights and Updates

Updated Category News Views 137

Akeso's Upcoming 2024 Financial Results Conference Call Akeso Inc. (9926.HK) is gearing up to hold an important conference call that will cover its final financial results for the year 2024. This call is scheduled for March 31, and it promises to provide valuable insights into the company's performance over the year and a glimpse into what the future may hold. Conference...

Continue Reading
Guerbet Shares Financial Projections and Key Events for 2026

Updated Category News Views 183

Guerbet's Financial Agenda Guerbet, a leading player in medical imaging, has outlined its financial agenda for 2026, sharing crucial publication dates that reflect its commitment to transparency and growth. With a history built on innovation, this agenda marks another step in Guerbet's journey as it continues to enhance the quality of healthcare through advanced imaging...

Continue Reading
BBT.live Showcases Innovative Solutions at VivaTech Paris 2025

Updated Category News Views 144

BBT.live Selected to Represent Innovative Technology at VivaTech BBT.live, a leader in secure connectivity solutions, is gearing up to showcase its groundbreaking platform at one of Europe's most significant innovation events. As an awarded startup, BBT.live will proudly join the official Israeli delegation at the highly anticipated VivaTech Paris 2025 event. BBT.live's...

Continue Reading
Mayhugh Commercial Advisors Celebrates Remarkable Growth in Deals

Updated Category News Views 125

Mayhugh Commercial Advisors Achieves 75 Deals This Year In an ever-changing commercial real estate sector, Mayhugh Commercial Advisors showcases exceptional performance. This year alone, the firm has successfully finalized 75 sales and lease agreements, highlighting its profound market understanding and outstanding professionalism. The Power of Teamwork This notable...

Continue Reading